Browse Category

NYSE:TFC News 6 January 2026 - 4 February 2026

UnitedHealth stock bounces even after Truist, JPMorgan trim targets as Medicare Advantage rates loom

UnitedHealth stock bounces even after Truist, JPMorgan trim targets as Medicare Advantage rates loom

UnitedHealth shares rose 1% to $289.75 Monday, outperforming peers as Humana, Elevance, and Cigna declined. Truist and JPMorgan cut price targets but kept positive ratings. Investors focused on Medicare Advantage payment rates and 2026 cost trends after last week’s sector sell-off. Final 2027 Medicare Advantage rates are expected in April.
Bank of America stock price slides into the weekend as bank shares sink; Fed decision and 10% card-rate cap watched

Bank of America stock price slides into the weekend as bank shares sink; Fed decision and 10% card-rate cap watched

Bank of America shares fell 1.4% to $51.72 Friday, part of a sharp selloff in U.S. bank stocks after First Citizens forecast lower net interest income for 2026. The KBE bank ETF dropped over 3%. Investors await next week’s Fed decision and details on a proposed 10% cap on credit-card rates. JPMorgan, Wells Fargo, and Citigroup also declined.
USB stock falls today as bank sector slides; U.S. Bancorp bond sale and Fed week in focus

USB stock falls today as bank sector slides; U.S. Bancorp bond sale and Fed week in focus

U.S. Bancorp shares fell 1.1% to $55.58 Friday afternoon, tracking a 3% drop in the SPDR S&P Bank ETF as regional banks slid after First Citizens BancShares’ weak outlook. The lender priced $2.25 billion in fixed-to-floating senior notes this week. Investors are focused on next week’s Federal Reserve meeting and its impact on bank margins. Wells Fargo, Bank of America, and JPMorgan also declined in afternoon trading.
CoreWeave stock rises as Wells Fargo trims target and insiders signal sales

CoreWeave stock rises as Wells Fargo trims target and insiders signal sales

CoreWeave shares rose 1.6% to $78.43 in midday Nasdaq trading Thursday after Wells Fargo cut its price target to $125 but kept a buy rating. Truist began coverage at Hold, citing growth and spending risks. CEO Michael Intrator filed to sell 61,386 shares worth about $4.7 million. The stock has swung sharply amid concerns over debt, data center delays, and AI infrastructure demand.
CoreWeave stock falls as Truist starts CRWV at Hold; Nvidia Rubin plan sharpens focus on AI capex

CoreWeave stock falls as Truist starts CRWV at Hold; Nvidia Rubin plan sharpens focus on AI capex

CoreWeave shares dropped 3.5% to $74.15 midday Tuesday after Truist Securities began coverage with a Hold rating and $84 target, citing high leverage and capital spending. The company said it will add Nvidia’s Rubin platform in late 2026. D.A. Davidson upgraded the stock a day earlier but warned of risks tied to heavy outlays and uncertain returns.

Stock Market Today

Coca-Cola stock price ends near $79 — frozen products exit sets up KO earnings week

Coca-Cola stock price ends near $79 — frozen products exit sets up KO earnings week

7 February 2026
Coca-Cola will discontinue its frozen products, including the Minute Maid frozen line, in the U.S. and Canada in Q1 2026. Shares closed Friday up 0.66% at $79.03 ahead of Tuesday’s quarterly results. CEO James Quincey sold 337,824 shares on Feb. 3 for about $26 million under a pre-arranged plan. Options pricing suggests a possible 3% move after earnings.
Cisco stock jumps 3% into earnings week as tech shakeout keeps CSCO in focus

Cisco stock jumps 3% into earnings week as tech shakeout keeps CSCO in focus

7 February 2026
Cisco shares closed up 3% at $84.82 Friday after a volatile week for tech stocks. The company will report quarterly results Feb. 11, with analysts expecting EPS of $1.02 on $15.12 billion revenue. U.S. jobs and inflation data, delayed by the federal shutdown, are also due next week. About 23.9 million Cisco shares traded Friday.
Go toTop